HOLLER FRANK A

CIK 00009388011 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0000938801

Recent Transactions

50 trades

Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-27$3.76/sh+36,008→ 160,628 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-27$18.88/sh−507→ 124,620 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-05-27−3,086→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-27$3.76/sh+3,086→ 125,127 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-27$18.68/sh−8,485→ 143,653 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-27$18.88/sh−5,911→ 154,717 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-05-27−36,008→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-27$18.69/sh−2,579→ 152,138 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-06-01+10,000→ 10,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-05-29$3.56/sh+3,086→ 122,041 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-05-29−3,086→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-20$9.39/sh−5,206→ 118,955 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-19$9.27/sh−7,600→ 124,161 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-18$9.28/sh−4,368→ 131,761 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-17$9.32/sh−5,069→ 136,129 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-16+15,000→ 15,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-12$9.38/sh−934→ 123,259 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-12−3,086→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-12−3,086→ 0 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-12$9.38/sh−7,781→ 141,198 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-12−25,720→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-12$3.70/sh+3,086→ 122,041 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-12$9.38/sh−934→ 121,107 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-12$3.07/sh+3,086→ 124,193 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-12$3.00/sh+25,720→ 148,979 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-06-04+15,000→ 15,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2018-03-14$3.77/sh+3,086→ 118,955 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-03-14−3,086→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-06-01+3,500→ 3,500 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-12-15$7.85/sh−30,000→ 115,869 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-08-19$7.65/sh−11,938→ 145,869 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-08-18$7.70/sh−9,599→ 157,807 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-08-17$7.89/sh−1,600→ 167,406 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2016-08-16$8.25/sh−6,863→ 169,006 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2016-06-02+3,500→ 3,500 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-11-24$9.39/sh−995→ 175,869 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-11-24−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-11-24$5.22/sh+2,057→ 176,864 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-08-18$11.00/sh−868→ 174,807 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-08-18−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-08-18$4.98/sh+2,057→ 175,675 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-05-04+3,086→ 3,086 total
Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2014-11-09+95,002→ 165,893 total
Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2014-11-09+2,737→ 173,618 total
Conversion
Xenon Pharmaceuticals Inc.$XENE
Series A Preferred Shares
2014-11-09−941→ 0 total
Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2014-11-09+941→ 1,184 total
Conversion
Xenon Pharmaceuticals Inc.$XENE
Series A Preferred Shares
2014-11-09−95,002→ 0 total
Conversion
Xenon Pharmaceuticals Inc.$XENE
Series B Preferred Shares
2014-11-09−4,988→ 0 total
Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2014-11-09+4,988→ 170,881 total
Conversion
Xenon Pharmaceuticals Inc.$XENE
Series E Preferred Shares
2014-11-09−2,737→ 0 total

Companies

Xenon Pharmaceuticals Inc.
Director
$XENE

Recent Filings

Address

C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov